Iatrogenic hypoglycemia is a complication of diabetes treatment that can cause harm and prevent optimal glycemic control. The problem can be minimized through the identification of risk factors, use of tools, appropriate drug regimens, and education. Every effort needs to be made to help minimize the risk and prevent the associated complications
Hypoglycaemia and its consequences represent a significant risk for many people who have type 2 diab...
If you regularly see patients with diabetes who experience hypoglycaemia and need expert guidance, t...
Hypoglycaemia is the most common acute complication of type 2 diabetes and can limit therapeutic eff...
Iatrogenic hypoglycemia is a complication of diabetes treatment that can cause harm and prevent opti...
Hypoglycemia caused by treatment with a sulfonylurea, a glinide, or insulin coupled with compromised...
The prevalence of type 2 diabetes mellitus (T2DM) is increasing all over the world. Targeting good g...
Hypoglycemia is an important complication of glucose-lowering therapy in patients with diabetes mell...
In this issue of Diabetes Care, McCoyet al. (1) report 3.4-fold higher mortal-ity in patients with d...
Type 2 diabetes carries a risk for hypoglycemia, particularly in patients on an intensive glucose co...
Three clinical phenomena have been defined in the last decade in patients with diabetes mellitus as ...
Iatrogenic hypoglycemia is a major limiting factor inthe strict glycemic management of diabetes (1,2...
Iatrogenic hypoglycemia is the limiting factor in theglycemic management of diabetes (1,2). It cause...
Glycemic control, a worthwhile goal for peoplewith diabetes, is limited by the barrier of iatro-geni...
Hypoglycemia is a common adverse event in patients with both type 1 and type 2 diabetes and may be a...
Three clinical phenomena have been defined in the last decade in patients with diabetes mellitus as ...
Hypoglycaemia and its consequences represent a significant risk for many people who have type 2 diab...
If you regularly see patients with diabetes who experience hypoglycaemia and need expert guidance, t...
Hypoglycaemia is the most common acute complication of type 2 diabetes and can limit therapeutic eff...
Iatrogenic hypoglycemia is a complication of diabetes treatment that can cause harm and prevent opti...
Hypoglycemia caused by treatment with a sulfonylurea, a glinide, or insulin coupled with compromised...
The prevalence of type 2 diabetes mellitus (T2DM) is increasing all over the world. Targeting good g...
Hypoglycemia is an important complication of glucose-lowering therapy in patients with diabetes mell...
In this issue of Diabetes Care, McCoyet al. (1) report 3.4-fold higher mortal-ity in patients with d...
Type 2 diabetes carries a risk for hypoglycemia, particularly in patients on an intensive glucose co...
Three clinical phenomena have been defined in the last decade in patients with diabetes mellitus as ...
Iatrogenic hypoglycemia is a major limiting factor inthe strict glycemic management of diabetes (1,2...
Iatrogenic hypoglycemia is the limiting factor in theglycemic management of diabetes (1,2). It cause...
Glycemic control, a worthwhile goal for peoplewith diabetes, is limited by the barrier of iatro-geni...
Hypoglycemia is a common adverse event in patients with both type 1 and type 2 diabetes and may be a...
Three clinical phenomena have been defined in the last decade in patients with diabetes mellitus as ...
Hypoglycaemia and its consequences represent a significant risk for many people who have type 2 diab...
If you regularly see patients with diabetes who experience hypoglycaemia and need expert guidance, t...
Hypoglycaemia is the most common acute complication of type 2 diabetes and can limit therapeutic eff...